Table 5: Adjusted EBITDA and Free Cash Flow (unaudited)
| ($ in millions) | Three months ended | ||||||||||
| April 2, 2023 | December 31, 2022 | April 3, 2022 | |||||||||
| GAAP Net income (loss) | $ | 623 | $ | 734 | $ | 666 | |||||
| Reconciling items to EBITDA (Non-GAAP) | |||||||||||
| Financial (income) expense | 82 | 103 | 105 | ||||||||
| (Benefit) provision for income taxes | 118 | 137 | 114 | ||||||||
| Depreciation | 160 | 158 | 142 | ||||||||
| Amortization | 123 | 144 | 168 | ||||||||
| EBITDA (Non-GAAP) | $ | 1,106 | $ | 1,276 | $ | 1,195 | |||||
| Reconciling items to adjusted EBITDA (Non-GAAP) | |||||||||||
| Results of equity-accounted investees | 2 | 6 | (12 | ) | |||||||
| Restructuring | 18 | (2 | ) | (1 | ) | ||||||
| Share-based compensation | 99 | 97 | 89 | ||||||||
| Other incidental items 1) | 42 | 8 | 8 | ||||||||
| Adjusted EBITDA (Non-GAAP) | $ | 1,267 | $ | 1,385 | $ | 1,279 | |||||
| Trailing twelve month adjusted EBITDA (Non-GAAP) | $ | 5,457 | $ | 5,469 | $ | 4,576 | |||||
| 1) Excluding depreciation/amortization within: | |||||||||||
| - other incidental items | $ | 2 | $ | — | $ | — | |||||
| ($ in millions) | Three months ended | ||||||||||
| April 2, 2023 | December 31, 2022 | April 3, 2022 | |||||||||
| Net cash provided by (used for) operating activities | $ | 632 | $ | 1,076 | $ | 856 | |||||
| Net capital expenditures on property, plant and equipment | (251 | ) | (233 | ) | (279 | ) | |||||
| Non-GAAP free cash flow | $ | 381 | $ | 843 | $ | 577 | |||||
| Trailing twelve month non-GAAP free cash flow | $ | 2,638 | $ | 2,834 | $ | 2,306 | |||||
| Trailing twelve month non-GAAP free cash flow as percent of Revenue | 20 | % | 21 | % | 20 | % | |||||
